Sorafenib-related adverse events predict survival in HCC treated with sorafenib combined with TACE

被引:0
作者
Yang, Man [1 ]
Qi, Xingshun [1 ]
Liu, Ziwei [1 ]
Nie, Yongzhan [1 ]
Han, Guohong [1 ]
Wu, Kaichun [1 ]
Fan, Daiming [1 ]
机构
[1] Xijing Hosp Digest Dis, Xian, Peoples R China
关键词
sorafenib; adverse events; overall survival; HCC;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:386 / 386
页数:1
相关论文
empty
未找到相关数据